Jason deBruyn Fresh off an acquisition that expanded its portfolio more broadly in the surgery market, Durham-based Bioventus reached a deal with Switzerland-based IBSA to secure exclusive U.S. distribution rights for a product for pain relief associated with osteoarthritis of the knee. The product, called GELSYN-3, is a hyaluronic acid (HA) and used to lubricate and cushion […]